Kiley Juergens Wealth Management, LLC Biogen Inc. Transaction History

Kiley Juergens Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$278.5 - $352.75 $105,551 - $133,692	-379 Closed	0 $0
Q3 2018 Oct 10, 2018	BUY	$293.51 - $383.83 $11,740 - $15,353	40 Added 11.8%	379 $133,000
Q2 2018 Jul 23, 2018	BUY	$257.52 - $306.91 $87,299 - $104,042	339 New	339 $98,000
Q1 2018 Apr 23, 2018	SELL	$260.13 - $367.91 $88,184 - $124,721	-339 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $104,289 - $116,812	339	339 $107,000

995

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Kiley Juergens Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kiley Juergens Wealth Management, LLC with notifications on news.